DE60135658D1 - In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung - Google Patents

In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung

Info

Publication number
DE60135658D1
DE60135658D1 DE60135658T DE60135658T DE60135658D1 DE 60135658 D1 DE60135658 D1 DE 60135658D1 DE 60135658 T DE60135658 T DE 60135658T DE 60135658 T DE60135658 T DE 60135658T DE 60135658 D1 DE60135658 D1 DE 60135658D1
Authority
DE
Germany
Prior art keywords
glucan
beta
soluble
production
cold water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60135658T
Other languages
English (en)
Inventor
Keith Raymond Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Granate Seed Ltd
Roxdale Foods Ltd
Original Assignee
Granate Seed Ltd
Roxdale Foods Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19927982&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60135658(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Granate Seed Ltd, Roxdale Foods Ltd filed Critical Granate Seed Ltd
Application granted granted Critical
Publication of DE60135658D1 publication Critical patent/DE60135658D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00—Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/10—Working-up residues from the starch extraction, e.g. potato peel or steeping water, including pressing water from the starch-extracted material
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/115—Cereal fibre products, e.g. bran, husk
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/20—Making of laminated, multi-layered, stuffed or hollow foodstuffs, e.g. by wrapping in preformed edible dough sheets or in edible food containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60135658T 2000-07-03 2001-07-03 In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung Expired - Fee Related DE60135658D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ50554500 2000-07-03
PCT/NZ2001/000133 WO2002002645A1 (en) 2000-07-03 2001-07-03 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME

Publications (1)

Publication Number Publication Date
DE60135658D1 true DE60135658D1 (de) 2008-10-16

Family

ID=19927982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135658T Expired - Fee Related DE60135658D1 (de) 2000-07-03 2001-07-03 In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung

Country Status (9)

Country Link
US (1) US20040023923A1 (de)
EP (1) EP1299424B1 (de)
JP (1) JP2004502794A (de)
AT (1) ATE407151T1 (de)
AU (2) AU8270801A (de)
CA (1) CA2413026C (de)
DE (1) DE60135658D1 (de)
ES (1) ES2313976T3 (de)
WO (1) WO2002002645A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2294180T3 (es) * 2001-12-11 2008-04-01 Ceapro Inc. Composiciones de beta-glucano de cereales, metodos de preparacion y usos de las mismas.
JP2006521828A (ja) * 2003-04-02 2006-09-28 カーギル，インコーポレイティド 低分子量グルカンを含んでなる、改良された食物繊維含有物質
EP1620469B1 (de) * 2003-05-02 2013-04-10 Ceapro Inc. Verfahren für die verbesserte extraktion und reinigung von beta (1-3) beta (1-4) glukan aus getreiden
CA2527029C (en) * 2003-06-10 2011-12-20 Ceapro Inc. Oral cereal beta glucan compositions
NZ545594A (en) * 2003-08-11 2009-09-25 Lesaffre Et Cie 41 Yeast cell walls for the treatment or prevention of hyperglycemia or for the stabilisation of glycemia
SE0401567D0 (sv) * 2004-06-17 2004-06-17 Biovelop Internat Bv Concentration of beta-glucans
EP1786280A1 (de) * 2004-07-02 2007-05-23 The Governors of the University of Alberta Wässrige lösungen, die beta-glucan und gummen enthalten
MX2007013725A (es) * 2005-05-05 2008-04-09 Sensient Flavors Inc Produccion de beta-glucanos y mananos.
AU2008251847B2 (en) * 2007-05-08 2013-09-26 Biothera, Inc. Particulate-soluble glucan preparation
JP5528718B2 (ja) * 2008-03-31 2014-06-25 株式会社Ａｄｅｋａ βグルカン組成物を用いた血糖値上昇抑制剤及びインスリン分泌促進剤
US20090285970A1 (en) * 2008-04-11 2009-11-19 Thava Vasanthan Solubility-reduced, beta-glucan containing products and methods of producing and using such products
US20100015306A1 (en) * 2008-07-15 2010-01-21 Pepsico, Inc. Method for Preparing a Low Viscosity Whole Grain Flour Slurry
JP2010100576A (ja) * 2008-10-24 2010-05-06 Unitika Ltd 便秘改善剤
JP5506229B2 (ja) * 2009-04-09 2014-05-28 サッポロビール株式会社 メタボリックシンドローム改善又は予防剤
WO2011061144A2 (en) 2009-11-20 2011-05-26 Basf Se The present invention relates to the use of beta-(1, 3)- beta-(1, 4) glucan with an average molecular weight of from 5.000 to 150.000 da for the increase of synthesis of collagen
AU2013203451B8 (en) * 2010-11-29 2015-10-29 Biotec BetaGlucans AS Glucan Gels
GB201020190D0 (en) * 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucans
GB201020191D0 (en) * 2010-11-29 2011-01-12 Biotec Pharmacon Asa Glucan gels
BR112013020889A2 (pt) * 2011-02-17 2016-09-27 Abbott Lab composições nutricionais solúveis em água compreendendo beta-glucana de cereal e amido resistente
BE1020120A3 (nl) * 2011-06-06 2013-05-07 Duynie Holding Bv Samenstelling van voedsel voor dieren.
EP2700321A1 (de) 2012-08-24 2014-02-26 Etablissements J. Soufflet Wässrige Lebensmittelzusammensetzung angereichert mit Beta-Glucan
EP3028583A1 (de) 2014-11-17 2016-06-08 Etablissements J. Soufflet Flüssiges, mit B-Glucan angereichertes Milchgetränk
SE540993C2 (en) 2017-05-29 2019-02-26 Creal Food Ab A process for preparation of cereal fractions
SE542822C2 (en) 2018-11-29 2020-07-14 Creal Food Ab A process for preparation of cereal fractions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3301848A (en) * 1962-10-30 1967-01-31 Pillsbury Co Polysaccharides and methods for production thereof
JPS5136359B1 (de) * 1968-10-14 1976-10-07
US4428967A (en) * 1979-06-12 1984-01-31 Research And Development Institute, Inc., At Montana State University Processes for production of waxy barley products
JPH0757761B2 (ja) * 1984-03-08 1995-06-21 株式会社林原生物化学研究所 β−グルカンとその製造方法及び用途
US4804545A (en) * 1984-08-10 1989-02-14 Barco, Inc. Production of beta-glucan, bran, protein, oil and maltose syrup from waxy barley
US5013561A (en) * 1984-08-10 1991-05-07 Barco, Inc. Process for recovery of products from waxy barley
CA1328074C (en) * 1988-09-01 1994-03-29 Shigenori Tanaka Horseshoe crab amebocyte lysate factor g inhibitor
US5084386A (en) * 1989-03-31 1992-01-28 Sri International Production of beta-1,3-glucan in euglena
US4996063A (en) * 1989-06-30 1991-02-26 The United States Of America, As Represented By The Secretary Of Agriculture Method for making a soluble dietary fiber composition from oats
US5458893A (en) * 1992-03-06 1995-10-17 The Quaker Oats Company Process for treating water-soluble dietary fiber with beta-glucanase
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5599697A (en) * 1992-12-14 1997-02-04 Takeda Chemical Industries, Ltd. Method of producing β-1,3-glucan
JP3532232B2 (ja) * 1992-12-14 2004-05-31 武田キリン食品株式会社 β−１，３−グルカンの新規製造法
CA2134138C (en) * 1994-01-24 1998-06-16 William E. Haast Lyophilized health food products and methods of making same
JPH07248297A (ja) * 1994-03-10 1995-09-26 Sapporo Breweries Ltd β−グルカンの測定法
US5512287A (en) * 1994-05-12 1996-04-30 Centennial Foods, Inc. Production of β-glucan and β-glucan product
US5576015A (en) * 1995-03-02 1996-11-19 Donzis; Byron A. Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses
ATE256472T1 (de) * 1996-09-25 2004-01-15 Gracelinc Ltd Beta-glukan produkte und deren extraktionsverfahren aus cerealien
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
US6143883A (en) * 1998-12-31 2000-11-07 Marlyn Nutraceuticals, Inc. Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system
US6083547A (en) * 1999-01-14 2000-07-04 Conagra, Inc. Method for obtaining a high beta-glucan barley fraction
WO2000056268A2 (en) * 1999-03-23 2000-09-28 New Zealand Institute For Crop & Food Research Limited Beta glucan extraction from cereals

Also Published As

Publication number Publication date
EP1299424A1 (de) 2003-04-09
WO2002002645A8 (en) 2003-02-06
ES2313976T3 (es) 2009-03-16
CA2413026C (en) 2009-12-22
EP1299424A4 (de) 2004-09-01
AU2001282708C1 (en) 2002-01-14
US20040023923A1 (en) 2004-02-05
CA2413026A1 (en) 2002-01-10
WO2002002645A1 (en) 2002-01-10
JP2004502794A (ja) 2004-01-29
AU8270801A (en) 2002-01-14
ATE407151T1 (de) 2008-09-15
AU2001282708B2 (en) 2007-01-04
EP1299424B1 (de) 2008-09-03

Similar Documents

Publication Publication Date Title
DE60135658D1 (de) In kaltem wasser lösliches -g(b)-glukanprodukt und verfahren zu dessen herstellung
CA2369070A1 (en) 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar radicals, methods for the production thereof, medicaments containing these compounds and the use thereof
ATE315050T2 (de) Verfahren zur herstellung von mehrfach vernetzten hyaluronsäurederivaten
NO20011539L (no) Hydrokolloid sukkervare
UY26655A1 (es) Composiciones gelificadas y gelificables para productos alimenticios
ATE302786T1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
ES2132359T3 (es) Procedimiento de purificacion de un polimero soluble hipocalorico de glucosa y producto obtenido.
DE60119711D1 (de) Verfahren zur herstellung von funktionalierten polyalkyleniminen, diese enthaltende zusammenstellungen und ihre verwendungen
WO2002028821A3 (de) Propionsäurederivate mit ppar-alpha aktivierenden eigenschaften.
ATE317259T1 (de) Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat
WO2004093867A3 (en) Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use
DE50101761D1 (de) Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäure
DE3768529D1 (de) Isohexid-nukleoside, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
ATE277886T1 (de) Verfahren zur herstellung von serinol
JPS5795995A (en) Phosphonoformaldehyde, manufacture and use as intermediate product for producing drug
DE69426495T2 (de) Weizensprossensaft enthaltendes stabiles präparat und verfahren zu seiner herstellung
JPH0725803B2 (ja) 水溶性低分子化キトサンの製造方法
JPS5399311A (en) Method for preparing of alimentary canals hormones of degestive organs
JPH01299294A (ja) ４，８−アンハイドロ−ｎ−アセチルノイラミン酸誘導体
JP2004196796A5 (de)
JPS5584504A (en) Coagulant
WO2003099870A3 (fr) Procedes d'obtention d'oligo-mannuronates et guluronates, les produits obtenus et leurs utilisations
JPS63245495A (ja) 両性界面活性剤の製造方法
DE69908771D1 (de) Tilidin-mesylat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen
KR960041195A (ko) 뇌 및 심혈관 질환에 유효한 프로필 글리콜만뉴로네이트 황산나트륨염과 그 제조방법

Legal Events

Date Code Title Description
8363 Opposition against the patent
8339 Ceased/non-payment of the annual fee